KORE Group Holdings, Inc. Common Stock (KORE)
2.5100
-0.0400 (-1.57%)
NYSE · Last Trade: Apr 3rd, 3:10 AM EDT

Via Benzinga · December 30, 2024

Via Benzinga · December 26, 2024

Via Benzinga · December 24, 2024

KORE Group shares are trading lower by 16.8% during Monday's session. The company late Friday announced a 1-for-5 reverse stock split.
Via Benzinga · June 24, 2024

Via Benzinga · December 16, 2024

Via Benzinga · December 13, 2024

Via Benzinga · December 11, 2024

Via Benzinga · November 20, 2024

KORE stock results show that Kore Group Holdings missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 15, 2024

Via Benzinga · July 12, 2024

KORE stock results show that Kore Group Holdings missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2023.
Via InvestorPlace · July 2, 2024

Via Benzinga · July 24, 2024

KORE stock results show that Kore Group Holdings missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

KORE stock results show that Kore Group Holdings missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 15, 2024

Companies Reporting Before The Bell • Kore Group Holdings (NYSE:KORE) is estimated to report quarterly loss at $0.05 per share on revenue of $77.79 million.
Via Benzinga · April 11, 2024

Via Benzinga · April 10, 2024

Via Benzinga · March 4, 2024

Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-expected sales for its fourth quarter.
Via Benzinga · February 28, 2024

Pre-market stock movers are a hot topic on Wednesday and we're starting this morning with a breakdown of all the biggest news moving shares!
Via InvestorPlace · February 28, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
Via Benzinga · January 9, 2024

Shares of Applied Therapeutics, Inc.
Via Benzinga · January 5, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
Via Benzinga · January 5, 2024